This article is more than 5 years old. Information may no longer be current.
Iridex MicroPulse patent revoked in Europe
Click Here to Manage Email Alerts
The European Patent Office has revoked the MicroPulse patent held by Iridex, according to a press release from OD-OS.
OD-OS sought the patent revocation in order to manufacture and market the Navilas laser system with microsecond pulsing technology.
The Navilas has computer-assisted laser delivery and digital documentation, the release said.
Using laser pulses down to 25 microseconds for treatment of retinal disorders was introduced and marketed as MicroPulse laser by Iridex.
“We fully respect the effort Iridex [Corporation] has put into the clinical development how tissue-sparing, shorter laser pulses can be effective for retinal treatments,” Winfried Teiwes, OD-OS managing director, said in the release. “With Navilas, we are providing a contact-free, easy-to-use and transparent delivery technique of these laser pulses, which allows standardized treatment protocols.”